198 related articles for article (PubMed ID: 10414445)
1. Irreversible labelling of the opioid receptors by a melphalan-substituted [Met5]enkephalin-Arg-Phe derivative.
Sartania N; Szatmári I; Orosz G; Rónai AZ; Medzihradszky K; Borsodi A; Benyhe S
Eur J Pharmacol; 1999 Jun; 373(2-3):241-9. PubMed ID: 10414445
[TBL] [Abstract][Full Text] [Related]
2. Receptor binding and G-protein activation by new Met5-enkephalin-Arg6-Phe7 derived peptides.
Bozó B; Farkas J; Tóth G; Wollemann M; Szucs M; Benyhe S
Life Sci; 2000 Feb; 66(13):1241-51. PubMed ID: 10737419
[TBL] [Abstract][Full Text] [Related]
3. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
4. Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: a mu specific affinity label for the opioid receptor.
Benyhe S; Hepp J; Simon J; Borsodi A; Medzihradszky K; Wollemann M
Neuropeptides; 1987 Apr; 9(3):225-35. PubMed ID: 3037428
[TBL] [Abstract][Full Text] [Related]
5. Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain.
Benyhe S; Farkas J; Tóth G; Wollemann M
J Neurosci Res; 1997 May; 48(3):249-58. PubMed ID: 9160247
[TBL] [Abstract][Full Text] [Related]
6. Binding profile of the endogenous novel heptapeptide Met-enkephalin-Gly-tyr in zebrafish and rat brain.
González-Nuñez V; Arsequell G; Szemenyei E; Toth G; Valencia G; Rodriguez RE
J Pharmacol Exp Ther; 2005 Aug; 314(2):862-7. PubMed ID: 15901806
[TBL] [Abstract][Full Text] [Related]
7. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to opioid receptors in frog brain membrane preparations.
Wollemann M; Farkas J; Tóth G; Benyhe S
J Neurochem; 1994 Oct; 63(4):1460-5. PubMed ID: 7931298
[TBL] [Abstract][Full Text] [Related]
9. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors.
Raffa RB; Kim A; Rice KC; de Costa BR; Codd EE; Rothman RB
Peptides; 1994; 15(3):401-4. PubMed ID: 7937312
[TBL] [Abstract][Full Text] [Related]
10. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
11. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
12. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
13. Kappa-receptor specificity of [Met5]enkephalyl-Arg-Gly-Leu and [Met5]enkephalyl-Arg-Gly-Leu-Lys.
Zajac JM; Ling N; Rossier J; Roques BP
Eur J Pharmacol; 1983 May; 90(1):147-8. PubMed ID: 6307718
[No Abstract] [Full Text] [Related]
14. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
15. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
Benyhe S; Ketevan A; Simon J; Hepp J; Medzihradszky K; Borsodi A
Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
[TBL] [Abstract][Full Text] [Related]
16. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone.
Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K
Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321
[TBL] [Abstract][Full Text] [Related]
17. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
Burkhardt C; Frederickson RC; Pasternak GW
Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to multiple sites in rat and guinea pig cerebellum.
Benyhe S; Farkas J; Tóth G; Wollemann M
Life Sci; 1999; 64(14):1189-96. PubMed ID: 10210261
[TBL] [Abstract][Full Text] [Related]
19. Melphalan potently substitutes the N-terminal Tyr of D-Ala2-Leu5-enkephalin methyl ester.
Szücs M; Di Gleria K; Medzihradszky K
FEBS Lett; 1985 Jan; 179(1):87-90. PubMed ID: 2981183
[TBL] [Abstract][Full Text] [Related]
20. Opioid activities of D-Arg2-substituted tetrapeptides.
Sato T; Sakurada S; Sakurada T; Furuta S; Chaki K; Kisara K; Sasaki Y; Suzuki K
J Pharmacol Exp Ther; 1987 Aug; 242(2):654-9. PubMed ID: 3612556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
